Close

Barclays Starts Theravance Inc. (THRX) at Overweight Nov 15, 2010 09:31AM
Barclays on U.S. Biotechnology Weekly: Still Early in Biotech Upside Trade Sep 27, 2010 01:15PM
Barclays maintains an 'Equalweight' rating on Theravance (THRX); HORIZON Data Generally inline, Candidiasis Rate Appears High Sep 23, 2010 02:05PM
Notable Analyst Rating Changes 03/30: MHGC, COBZ, PRXL Upgraded; GENZ, RTI, GNVC Downgraded Mar 30, 2010 10:52AM